XORTX Therapeutics Inc. (XRTX) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
애널리스트 추정 주당순이익(EPS) $-1.50 및 매출 $0.00B 다음 회계연도.
주당순이익(EPS) 실적 추이: 2024: 실적 $-7.90 vs 추정 $-1.50 (하회 -426.7%). 2025: 실적 $-3.90 vs 추정 $-0.69 (하회 -465.1%). 애널리스트 정확도: 18%.
